Formulary Committee members with a potential conflict of interest permission to participate in committee communications and discussions

This bill modifies the rules for Minnesota's Formulary Committee, which oversees drug coverage decisions for state medical assistance programs. It clarifies that members with potential conflicts of interest may participate in discussions, provided they disclose the conflict and recuse themselves from voting on affected matters. The legislation also mandates that the committee seek input from the Minnesota Rare Disease Advisory Council and creates a public process for submitting comments on drug recommendations. Furthermore, it defines specific financial thresholds for personal interests and requires public disclosure of conflict forms before committee meetings.